The Current Ratio as of November 2024 (TTM) for Jaguar Health, Inc. (JAGX) is 1.84

According to Jaguar Health, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.84. This represents a change of -5.83% compared to the average of 1.96 of the last 4 quarters.

Jaguar Health, Inc. (JAGX) Historical Current Ratio (quarterly & annually)

How has JAGX Current Ratio performed in the past?

The mean historical Current Ratio of Jaguar Health, Inc. over the last ten years is 1.16. The current 1.84 Current Ratio has changed 15.77% with respect to the historical average. Over the past ten years (40 quarters), JAGX's Current Ratio was at its highest in in the June 2015 quarter at 4.69. The Current Ratio was at its lowest in in the December 2017 quarter at 0.25.

Jaguar Health, Inc. (JAGX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Jaguar Health, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Jaguar Health, Inc. (JAGX) Average Current Ratio

How has JAGX Current Ratio performed in the past?

The current Current Ratio of Jaguar Health, Inc. (JAGX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Jaguar Health, Inc. (JAGX) Current Ratio vs. Peers

How is JAGX’s Current Ratio compared to its peers?

Jaguar Health, Inc.’s Current Ratio is less than Onconova Therapeutics, Inc. (1.93), less than iBio, Inc. (3.37), less than GeoVax Labs, Inc. (4.17), less than Ocugen, Inc. (2.58), greater than eFFECTOR Therapeutics, Inc. (1.03), less than Virios Therapeutics, Inc. (7.27), less than Zura Bio Limited (10.36), greater than Navidea Biopharmaceuticals, Inc. (0.56), greater than ZyVersa Therapeutics, Inc. (0.03), less than Tonix Pharmaceuticals Holding Corp. (3.33), less than Acasti Pharma Inc. (7.86), less than Diffusion Pharmaceuticals Inc. (10.96), less than Phio Pharmaceuticals Corp. (6.38), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65), greater than 180 Life Sciences Corp. (0.19), less than Cardio Diagnostics Holdings, Inc. (8.51), greater than Vaxart, Inc. (0.83), greater than VBI Vaccines Inc. (0.34),

Build a custom stock screener for Jaguar Health, Inc. (JAGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jaguar Health, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jaguar Health, Inc. (JAGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jaguar Health, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.